510(k) · Cleared

Cleared

Revised C-Reactive Protein (RCRP) Flex Reagent Cartridge

K990825510(k) TraditionalCleared Apr 16, 199935-day reviewClass II21 CFR 866.5270

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · DCN System, Test, C-Reactive Protein

Cleared on Apr 16, 1999 as substantially equivalent to K962523 (Behring Diagnostics, Inc., 1996) after a 35-day review. Its family tree reaches back 2 generations to 1986.

Decided: Apr 16, 1999
Review: 35 days
Class: Class II
Product code: DCN
Recalls: None
Predicates: 1

Its longest line of descent runs back 2 generations to K860894 (1986). No later device cites it as a predicate yet.

By dateBy generation

Root · 2 generations backK860894 Behring Nephelometer SystemBehring Diagnostics, Inc. · 1986
1 generation backK962523 N Latex CRP Mono ReagentBehring Diagnostics, Inc. · 1996
This deviceK990825 Revised C-Reactive Protein (RCRP) Flex Reagent CartridgeDade Behring, Inc. · 1999

View FIG. 1 as a table

Line of descent and top descendants

Generation	Number	Device	Applicant	Decided	Recalls
−2	K860894	Behring Nephelometer System	Behring Diagnostics, Inc.	1986	—
−1	K962523	N Latex CRP Mono Reagent	Behring Diagnostics, Inc.	1996	—
0 (this device)	K990825	Revised C-Reactive Protein (RCRP) Flex Reagent Cartridge	Dade Behring, Inc.	1999	—

FIG. 1 — Lineage of K990825, 1986–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DCN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DCN device

#1 K232624 CardioPhase® hsCRPscore 6.7 · 2 generations · no Class I recall
#2 Held for the reportin the report
#3 Held for the reportin the report

Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

Type	Number	Device	Applicant	Decided	Recalls
*	K962523	N Latex CRP Mono Reagent Summary page 1 …e of Product: Revised C-Reactive Protein (RCRP) Flex™ reagent cartridge FDA Classification Name: C-Reactive Protein Test System Predicate Device: N Latex CRP mono assay (K962523) Device Description: The RCRP method is based on a particle enhanced turbidmetric immunoassay (PETIA) technique. Latex particles…	Behring Diagnostics, Inc.	1996	—

Also cleared against K962523: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

The line of descent spans 13 years and passes through 2 companies; a new generation was cleared every 10.2 years on median.
None of the 2 ancestors has a recall.
2 other devices also cite its predicate K962523.

How does its category compare?

All DCN devices

DCN System, Test, C-Reactive Protein: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DCN

2in 2023

2007high 3 (2009) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DCN

234in 2018

2007high 234 (2018) · low 111 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DCN

1in 2020

2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DCN

7in 2025

2007high 8 (2019) · low 0 (2007)2025

MAUDE reports naming product code DCN, not matched to any one device; reports are not rates.

View these four charts as a table

Year	Decisions	Median 510(k) review, days	Recalls (Class I)	MAUDE reports
2007	1	—	0	0
2008	2	—	1	0
2009	3	111	0	0
2010	1	—	0	2
2011	0	—	0	5
2012	1	—	0	2
2013	0	—	0	0
2014	0	—	0	2
2015	0	—	0	2
2016	0	—	0	1
2017	1	—	0	0
2018	3	234	0	2
2019	0	—	1	8
2020	1	—	1	0
2021	0	—	0	1
2022	0	—	0	1
2023	2	—	0	3
2024	0	—	0	5
2025	0	—	0	7
2026	0	—	1	—

What is it indicated for?

The Revised C-Reactive Protein (RCRP) Flex™ reagent cartridge for the Dimension® clinical chemistry system is an in vitro diagnostic device intended to quantitatively measure C-reactive protein in human serum and plasma. Measurements of C-reactive protein are used in the evaluation of the amount of injury to body tissues.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

https://510kreport.com/device/K990825 · printed Nov 4, 2026

Cite this page

510(k) Report. “K990825: Revised C-Reactive Protein (RCRP) Flex Reagent Cartridge.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K990825

Report an extraction error

Are you the manufacturer?

Record history

FDA decision record loaded May 2, 2026
Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
Lineage and recalls computed Nov 3, 2026
Page last updated Nov 3, 2026